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FIGURE 1. Meta-regression plot of male proportion (%) on standardized mean difference (SMD)
of myocardial enzyme levels (coefficient, –0.022; P ¼ .098). The area of each circle is inversely
proportional to the variance of the SMD. Data taken from Zhou and colleagues.5
Letters to the Editorconditioning.4 Moreover, our recent
study,5 including 10 randomized trials
using the meta-regression method
found an increased effect size (stan-
dardized mean difference) in postin-
tervention myocardial enzyme levels
of ischemic postconditioning by 0.22
per 10% increase in male proportion
(Figure 1), indicating that a study
with more male patients may result in
a more pronounced effect than a study
with fewer male patients. Hence, in
their fundamental study, the authors
cannot exclude the potential role of
gender disparity in the quasi preserva-
tion of cardioprotection by RIPC with
isoflurane, but not propofol, in CABG.
At least, as the authors stated in the
limitation section, both positive and
negative controls are essential in one
study, especially for the exploration
of the role of STAT 5. The cardiopro-
tective difference between isoflurane
and propofol in the setting of RIPC
needs further more rigorous studies.
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We thank Zhou and colleagues for
their comments and interest in our
recent work.1,2 We appreciate that
they considered us to have done
a series of impressive translational
studies to explore the mechanisms of
cardioprotection by remote ischemic
preconditioning (RIPC) with isofluraneof Thoracic and Cardiovascular Surgeor propofol in patients undergoing
coronary artery bypass grafting
(CABG) surgery.1-3
Zhou and colleagues speculate that
there might be an unrecognised effect
of gender on the protection provided
by RIPC and, thus, on our results.
They underline this speculation by a
meta-analysis including 10 random-
ized trials. However, these data are
derived from studies related to
ischemic postconditioning,4 rather
than RIPC, and these 2 phenomena
may be mechanistically different.5
In our studies, in contrast to others
that have not addressed the impact of
anesthetics,6 we showed that propofol
interferes with the protection by
RIPC, whereas the volatile anesthetic
isoflurane2 does not. Furthermore,
the activation of signal transducer
and activator of transcription 5 phos-
phorylation may be part of the mecha-
nism by which RIPC exerts its
cardioprotection during isoflurane
anesthesia.1,3 Indeed, the gender
distribution in our studies was not
comparable in all subgroups.1,2
Certainly, therefore, effects provided
by RIPC may be modified by gender,
but this has not been studied. We
agree that it would be worthwhile to
examine whether there is a gender-
specific effect of cardioprotection not
only by ischemic postconditioning but
also by RIPC. However, our studies
were neither designed nor powered to
examine a potential role of gender
disparity. Therefore, we can neither
exclude nor confirm gender effects on
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I enjoyed the recent article,
‘‘‘Corkscrew stenosis’: Defining and
preventing a complication of percuta-
neous dilatational tracheostomy,’’ by
Jacobs and colleagues1 in the February
issue of The Journal of Thoracic and
Cardiovascular Surgery.
We have performed percutaneous
tracheostomy for longer than 10 years
at our Medical Center. We have not
seen an increase in postpercutaneous
tracheal stenosis, and have not per-
formed a tracheal resection for this
complication. When performing percu-
taneous tracheostomy, we attempt to
place the tracheostomy lower on the
anterior wall of the trachea (ie, just
below the thyroid isthmus) to
avoid the isthmus and subsequent
bleeding into the tracheobronchial
tree.
If the tracheostomy with dilator
does not pass easily into the trachea,
we dissect the subcutaneous tissue
and/or dilate the tracheal opening
with a standard tracheal dilator or734 The Journal of Thoracic and Cclamp. These steps usually allow
easy passage of the tracheostomy.
We instruct our bronchoscopist,
usually the anesthesiologist, to pull
back the endotracheal tube so that
we enter the trachea without
impaling the endotracheal tube. Un-
der these circumstances, the endotra-
cheal tube is just proximal in the
airway to where the tracheostomy is
being inserted. When the endotra-
cheal tube is positioned just prox-
imal to the tracheostomy insertion
site, anterior tracheal ring fracture
is prevented (as described by the
authors).
We agree with the authors that the
positioning of the supportive endo-
tracheal tube is important in prevent-
ing anterior tracheal ring fracture.
We also believe that placing the
tracheostomy just inferior to the
thyroid isthmus, which may serve
as a cushion for the anterior tracheal
ring, and dilating the skin incision or
tracheal opening itself have pre-
vented us from experiencing this
complication.
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We greatly appreciated the thought-
ful review of our article provided
by Dr Baciewicz. Furthermore, the
suggestions offered by Dr Baciewicz
are of great interest and work well at
his center, where he has not seen ‘‘cork-
screw’’ tracheal stenosis after percuta-
neous dilatational tracheostomy (PDT)ardiovascular Surgery c September 201in the same way that we have been
receiving them at our referral center.
We agree that adequate dissection
of soft tissue anterior to the trachea
is critical in avoiding excessive force
and torque when advancing the
dilator, which can lead to tracheal
ring fractures, as described. Because
this is a minimally invasive means of
providing a tracheostomy, there is
often a tendency to make the skin inci-
sion as small as possible. This should
be avoided. An incision large enough
to accommodate the dilator and then
the tracheostomy without great resis-
tance should be made (at least 1.5-2
cm). Furthermore, using a clamp to
dissect and spread the soft tissue ante-
rior to the trachea is similarly impor-
tant and done routinely at our
institution.
DrBaciewicz also describes dilating
the actual trachea with a tracheal
dilator or clamp when there is diffi-
culty passing the tracheostomy with
the dilator. Thiswas first described dur-
ing the percutaneous technique by
Griggs and colleagues1 in 1990 using
guidewire dilating forceps. Since then,
this technique has been compared
with the single-step curved dilator
technique in multiple small random-
ized studies, most of which found
the 2 techniques similar.2-4 We use
the Griggs technique in a few of our
cases (3%) when we encounter a
trachea that is particularly difficult to
dilate. These tenacious tracheas are
most often encountered in young
patients, and we agree that the Griggs
technique is an important maneuver
that should be in the armamentarium
of those performing PDTs.
We appreciate the comments pro-
vided regarding the location of place-
ment along the trachea. Dr Baciewicz
recommends placing the tracheos-
tomy lower along the anterior tracheal
wall just inferior to the thyroid
isthmus. We agree with the ‘‘low’’
placement of the tracheostomy to a
certain extent. The tracheostomy
placement should be low enough that
it does not risk injuring the cricoid3
